A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals

Clinical trial NCT02242656 · WITHDRAWN

Trial details

NCT number: NCT02242656
Sponsor: Marathon Pharmaceuticals, LLC
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Short Bowel Syndrome Short Gut Syndrome SBS Short Bowel Short Gut

Start date: 2014-12-01
Primary completion: 2017-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.